1
/
of
0
FDA Drug Approval, N018140, ATIVAN
FDA Drug Approval, N018140, ATIVAN
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 018140
Company: HIKMA
Drug Name: ATIVAN
Active Ingredients: LORAZEPAM
Strength: 4MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/25/1980
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: HIKMA
Drug Name: ATIVAN
Active Ingredients: LORAZEPAM
Strength: 4MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 07/25/1980
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details